Britain confirmed its initial six cases of a Brazilian COVID-19 variant infection that ministers had been desperately attempting to keep out of the country.
The variant, scientifically named P1, as shown on Sky News's YouTube video below, has mutated in a manner that seems to make it more possible to infect humans who caught other variants of COVID-19, or those who have been vaccinated.
It was initially detected in Manaus, a city with two million residents, in the middle of the Amazon Rainforest in late 2020.
The city suffered an enormous outbreak in spite of being thought to have high protection levels from the earlier transmission of the virus, with many people getting infected, dealing a great blow to the notion that herd immunity might occur naturally.
Researchers have since picked up on strain in at least 25 nations globally, including the United Kingdom, the United States, Italy, Belgium, Switzerland, Ireland and France, among others.
Mail Online reported, that experts said that vaccines might be less efficient against it although they are still possible to work and it is not likely to turn into the dominant variant in the UK.
The 'P1 Brazilian' Variant
The P1 variant is one of the two strains discovered in Brazil and it is the more alarming of the two due to a key mutation identified as E484K.
E484K has been detected on the South African strain and research said that it changes the shape of the virus in a manner that changes how the immune system is recognizing it.
More so, the body uses highly-specific proteins known as antibodies to tackle the virus when it reaches the body, and antibodies made to suit one virus typically won't fit another.
If the COVID-19 infection mutates too much, it can begin to look like a different virus and antibodies made as a reaction to an older strain might not recognize the new one. This can then lower the success rate they have written when destroying the new strain.
This seems to be occurring with the South African strain, as well as the P1 Brazilian variant, making reinfections, as well as, in theory, contagion after vaccination more possible.
Nonetheless, the virus is still recognized by the majority of the immune system and researchers are confident that immunity will work through the board at stopping death and severe disease.
Essentially, antibodies are just a part of the immune system, an easily gauged part, which is the reason they are essential in research. Other substances like white blood cells can enhance the immunity of people but may be more difficult to gauge in studies.
Efficacy of Vaccines
Scientists are now expecting that current vaccines can prevent death and severe illness resulting from the P1 strain, although they may be less efficient than they were during the trials.
This is due to the fact that its ability to escape some of the immune cells made in reaction to other variants of the virus mentioned earlier.
This may mean that the body is making lesser antibodies to combat the virus although research on the South African variant has shown people still seem to make enough of the antibodies for them to be immune.
Professor Adam Finn, a Joint Committee on Vaccination and Immunization or JCVI member and an expert from the University of Bristol said that at present, the evidence they have is suggesting that certainly, the strain from South Africa, and potentially the Brazilian P1 variant, which is somewhat similar, the vaccines currently available are less effective at lowering at least mild disease and perhaps in transmission.
RELATED ARTICLE : UK Scientists Trying a New Drug to Prevent Spread of Infection Leading to COVID-19
Check out more news and information on COVID-19 on Science Times.
